Literature DB >> 17520987

Urine drug test interpretation: what do physicians know?

Gary M Reisfield1, Roger Bertholf, Robert L Barkin, Fern Webb, George Wilson.   

Abstract

OBJECTIVE: To determine the level of urine drug test (UDT) interpretive knowledge of physicians who use these instruments to monitor adherence in their patients on chronic opioid therapy.
METHODS: A seven-question instrument consisting of six five-option, single-best-answer multiple choice questions and one yes/no question was completed by 114 physicians (77 who employ UDT and 37 who do not) attending one of three regional opioid education conferences. We calculated frequencies and performed chi2 analyses to examine bivariate associations between UDT utilization and interpretive knowledge.
RESULTS: The instrument was completed by 80 percent of eligible respondents. None of the physicians who employ UDT answered all seven questions correctly, and only 30 percent answered more than half correctly. Physicians who employ UDT performed no better on any of the questions than physicians who do not employ UDT.
CONCLUSIONS: Physicians who employ UDT to monitor patients receiving chronic opioid therapy are not proficient in test interpretation. This study highlights the need for improved physician education; it is imperative for physicians to work closely with certified laboratory professionals when ordering and interpreting these tests.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520987     DOI: 10.5055/jom.2007.0044

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  13 in total

1.  Erratum To: Implementation of a Blind Quality Control Program in Blood Alcohol Analysis.

Authors:  Jackeline Moral; Callan Hundl; Dayong Lee; Maddisen Neuman; Aimee Grimaldi; Maria Cuellar; Peter Stout
Journal:  J Anal Toxicol       Date:  2021-05-14       Impact factor: 3.367

Review 2.  Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?

Authors:  Krishnan Chakravarthy; Aneesh Goel; George M Jeha; Alan David Kaye; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2021-02-17

3.  Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.

Authors:  Jessica J Wyse; Benjamin J Morasco; Steven K Dobscha; Michael I Demidenko; Thomas H A Meath; Travis I Lovejoy
Journal:  J Opioid Manag       Date:  2018 Jul/Aug

4.  Toxicologic testing for opiates: understanding false-positive and false-negative test results.

Authors:  Christopher J Keary; Ying Wang; Jonathan R Moran; Lazaro V Zayas; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2012-07-26

5.  They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.

Authors:  Joanna L Starrels; Aaron D Fox; Hillary V Kunins; Chinazo O Cunningham
Journal:  J Gen Intern Med       Date:  2012-07-20       Impact factor: 5.128

6.  Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings.

Authors:  Rachel Ceasar; Jamie Chang; Kara Zamora; Emily Hurstak; Margot Kushel; Christine Miaskowski; Kelly Knight
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

Review 7.  Urine Drug Testing in Cancer Pain Management.

Authors:  Joseph A Arthur
Journal:  Oncologist       Date:  2019-10-11

8.  Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids.

Authors:  Joji Suzuki; Stephanie Garayalde; Martekuor Dodoo; Claudia Rodriguez
Journal:  Subst Abus       Date:  2018-10-16       Impact factor: 3.716

9.  Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.

Authors:  Isaac Chua; Athena K Petrides; Gordon D Schiff; Jaime R Ransohoff; Michalis Kantartjis; Jocelyn Streid; Christiana A Demetriou; Stacy E F Melanson
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

10.  Primary care providers’ judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults.

Authors:  Maya Vijayaraghavan; Joanne Penko; David Guzman; Christine Miaskowski; Margot B Kushel
Journal:  J Gen Intern Med       Date:  2011-04       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.